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Abstract
 
Understanding the effects of population diversity on cancer-related experiences is a
priority in oncology care. Previous research demonstrates inequalities arising from
variation in age, gender and ethnicity. Inequalities and sexual orientation remain
underexplored. Here, we report, for the first time in the UK, a quantitative secondary
analysis of the 2013 UK National Cancer Patient Experience Survey which contains
70 questions on specific aspects of care, and six on overall care experiences. 68,737
individuals responded, of whom 0.8% identified as lesbian, gay or bisexual.
Controlling for age, gender and concurrent mental health comorbidity, logistic
regression models applying post-estimate probability Wald tests explored response
differences between heterosexual, bisexual and lesbian/gay respondents. Significant
differences were found for 16 questions relating to: (a) a lack of patient-centred care
and involvement in decision making, (b) a need for health professional training and
revision of information resources to negate the effects of heteronormativity, and (c)
evidence of substantial social isolation through cancer. These findings suggest a
pattern of inequality, with less positive cancer experiences reported by lesbian, gay
and (especially) bisexual respondents. Poor patient-professional communication and
heteronormativity in the healthcare setting potentially explain many of the differences
found. Social isolation is problematic for this group and warrants further exploration.
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Introduction
 
Across all aspects of cancer care, there is an important drive to explore the effects of
population diversity. Recent work has demonstrated inequalities in the patient-
reported experience arising from variation in age, gender (Din et al, 2015) and
ethnicity (Naylor, Ward & Polite, 2012). Far less is known about the impact of sexual
orientation on cancer care experiences (Quinn et al 2015). The differential
experiences of lesbian, gay and bisexual (LGB) cancer patients is important to
understand, not least because this group is at increased risk of specific cancers. Pre-
menopausal lesbian and bisexual women have higher risk of breast, cervical, ovarian
and lung cancers compared to heterosexual women (Boehmer et al, 2012; Clavelle
et al, 2015) and gay men are at increased risk of anal cancer beyond that risk
observed in heterosexual men (Chin-Hong et al, 2005; Goldstone et al, 2011).
Overall, gay men are reported to be 1.9 times more likely to have cancer over their
lifetime compared with heterosexual men (Boehmer, Miao & Ozonoff, 2011).  Much
of this increased risk is likely due to lifestyle and health behaviour factors, such as
alcohol use and smoking (Hagger-Johnson et al, 2013).
 
 
Sexual orientation data is not routinely collected in either clinical practice or research
(Kamen et al, 2015): this results in very little knowledge about how sexuality impacts
cancer outcomes or experiences of care. A recent scoping review (Semlyen &
Hulbert-Williams, 2013) summarised existing literature demontrating that LGB
patients, when compared to heterosexuals, report poorer quality of life, anxiety and
depression (Boehmer et al, 2011; Boehmer, Glickman & Winter, 2012) and more
negative experiences of care and support during treatment (Matthews et al, 2012)
but found a dearth of information on experiences of survivorship care.  A more recent
study partly addresses cancer survivorship, reporting a disparity in psychological
distress in gay men compared to heterosexual men (Kamen et al, 2014). The
majority of current knowledge focuses on lesbian or gay people’s experiences of
cancer, and few studies explore the needs or experiences of bisexual patients;
whether this results from a lack of dedicated funding, insufficient expertise or interest
within oncology research, or that previous attempts to undertake work with bisexual
patients has failed to produce publishable results (for example, failure to identify and
recruit sufficient participant numbers) is unclear. Regardless, comparative research
of the experiences of all groups of sexual orientation is essential to identify and
address cancer care inequality.
 
Large scale research in this area is sparce and secondary analysis of large datasets
may be useful. One recent example of this describes sexual orientation inequality in
psychological distress resulting from cancer in a large US dataset (Kamen et al,
2015). The authors highlight important differences in distress based on the
intersection of sexual orientation and gender, and that differences in support
perceived as being available to different demographic sub-sets of patients may be an
overall explanatory factor in predicting distress levels.
 
The UK National Cancer Patient Experience Survey (NCPES) lends itself to a similar
secondary analysis of UK cancer experiences.  Distributed annually to patients who
receive cancer treatment in the UK, results are used to explore service provision
differences and track quality improvement over time. Although differences in relation
to sexual orientation were initially explored in the 2013 National Report (Quality
Health, 2013) this did not statistically control for potentially confounding variables
and grouped participants in such a way that makes interpretation of results difficult.
 
This paper reports a more rigorous secondary analysis of the 2013 NCPES data,
aiming to understand how the experiences of LGB patients with cancer differ from
those of heterosexual patients. There are inherent problems with using secondary
data, most notably including the small numbers identifying as LGB, and issues
pertaining to the wording of specific questions: these will be discussed in detail later
in this paper. The NCPES is, however, the largest dataset of cancer experience that
enables analysis of this type and despite methodological and sampling limitations
thus provides a valuable resource for exploratory analysis in this under-researched
field. We adopt an epistemologically explorative stance; our intention is to highlight
areas of potential inequality to inform future research. This analysis is the first of its
kind within the UK cancer context.
 
 
Methods
The NCPES contains 72 self-report questions about cancer care: 66 focus on
specific areas of care (e.g. interaction with healthcare professionals, provision of
information etc.) and six focus on overall experiences. Nine demographic questions
are asked, including one on sexual orientation. The survey was conducted by Quality
Health and responses are matched to electronic hospital records for accurate clinical
information. We used data from the 2013 survey: this was sent out to patients who
received cancer treatment between 1st September and 20th November 2012.  Ethical
approval for the original survey (including later secondary uses of the data) was
obtained by Quality Health from the Ethics and Confidentiality Committee of the
National Information Governance Board (Ref: ECC 6-02(FT4)/2012).  Data from the
survey were deposited to the UK Data Service under End User Licence (EUL)
Conditions (Department of Health, 2013); following registration with the UK Data
Service we were permitted to download the data for secondary analysis.
 
Participants
The 68,737 survey respondents represented a 64% response rate. 53% were
female, 63% were retired, and their mean age was 66.3 years (SD=12.36). 96%
identified as white-British indicating under representation of black and minority ethnic
populations. 66% of respondents were within the first year since diagnosis.  Although
all cancer sites were represented, 49% were diagnosed with one of the four most
common cancers in the UK (breast, colorectal/lower gastro-intestinal, prostate, lung).
Sexual orientation was determined by response to the question “Which of the
following best describes your sexual orientation?”. 89.3% of respondents identified
as heterosexual/straight; 425 (0.6%) identified as lesbian or gay; 143 (0.2%)
identified as bisexual; 0.9% of respondents chose ‘other’; and 3% indicated a
preference not to answer.  A further 6% left the question blank. The small numbers
identifying as LGB are unlikely to represent accurate population proportions of these
sexual identities in the UK. The British National Survey of Sexual Attitudes and
Lifestyles (NATSAL) for example, reported that 2.5% of men, and 2.4% of women
self-identify as LGB, and an increasing number of both men and women report
engaging in same-sex sexual behaviour (Mercer et al, 2013). Though we can only
speculate on reasons for this, it is likely that this reflects an ongoing unwillingness to
disclose sexual orientation in the context of the NCPES, which is compounded by
the older mean age of the overall sample. A full sociodemographic and clinical
comparison table of respondents to the NCPES used for this secondary analysis can
be viewed in table 1.
 
***INSERT TABLE 1 ABOUT HERE***
 
Analysis
Sexual orientation was operationalised as three categories: heterosexual, bisexual,
and lesbian/gay. Though an argument could be made to group the participants
differently, our choice was informed by three considerations.  First, it allowed a
cleaner disambiguation between gender and sexual orientation: had we, for
example, analysed lesbian and gay respondents separately we would not
necessarily know whether the differences were a result of sexual orientation or
gender differences unless we had also split the heterosexual and bisexual group in
the same way.  With such low participant numbers in the LGB groups already, further
fragmentation would have reduced statistical power and increased the potential for
Type I error; this was our second consideration.  Instead, a more statistically rigorous
approach was to test and control for the confounding effects of gender (and other
demographic variables) across the entire sample; had we split the lesbian and gay
group by gender and made a gender-based statistical control, we would be
accounting for the effects of gender twice in some participant groups, but only once
in the others which would be inappropriate. Power could have been increased further
by merging lesbian, gay and bisexual into one category, however we had no strong a
priori reasoning for assuming the experiences of bisexual and lesbian and gay
participants would be similar enough to be grouped in this way; indeed, our results
support this decision by finding clear differences between the two groups. Finally, it
maintained participant grouping as defined by the participants themselves in
response to the sexual orientation question on the survey.
Those who responded ‘other’ or who indicated a preference not to answer were not
included in the analysis. Whilst no explicit assumption is made about the type of
missing data, it is unlikely that it occurs randomly in all cases; we thus did not impute
sexuality to avoid adding bias.
 
 
Multinomial logistic regression (with sexual orientation as the dependent variable)
was used to identify socio-demographic and clinical confounders. Gender, age, and
concurrent mental health comorbidity were each statistically significant in predicting
the likelihood of sexual orientation (three categories: heterosexual, lesbian and gay,
bisexual), and so were selected as independent variables for later analyses. Level of
education, ethnicity and physical health co-morbidities were not significant and so
were not included in the later analyses. We were unable to account for differences in
cancer type or treatment due to small sub-group sizes in the lesbian/gay and
bisexual groups.
 
Logistic regression analyses were performed for each question with sexual
orientation, gender, age and concurrent mental health comorbidity forced into each
model as independent variables. Questions with multiple response options were
analysed using ordinal or multinomial logistic regression, depending on whether
categories had a natural ordering.  The significance of differences in response by
category of sexual orientation were explored, applying post-estimation probabilities
using Wald tests.  Wald tests are based upon the estimated variance-covariance
matrix of estimators and are asymptotically equivalent to likelihood ratio tests.
However, they have the advantage of requiring only one model, thus offering a
pragmatic alternative in the case of multiple analyses (Long & Freese, 2006).
Analyses were performed in Stata 13.
We explored differences in responses to all questions except for question 66 (Have
you had treatment from any of the following for your cancer? Response options:
physiotherapist, occupational therapist, dietician, speech and language therapist,
lymphoedema specialist) as data here was recorded only if patients answered in the
affirmative. As a result, positive response rates varied considerably (9% to 38%)
across each category. It is unsafe to assume that where participants left this question
blank that this corresponded to a negative response, and as such the data could not
be considered robust.
We employed an exploratory rather than hypotheses-driven approach to analysis
(Grove & Andreasen, 1982) adopting a standard alpha level of 0.05 for statistical
significance, but without making any adjustment (e.g. Bonferroni Correction) for
multiple testing; such corrections are used to reduce probability of Type I error but as
we had no a priori hypotheses this was not relevant to our study aim.
 
Results
Complete data was available for sexual orientation and control variables for 57,402
respondents; the remaining 16% of participants were excluded from this analysis. In
16 of 69 questions analysed, sexual orientation was a significant predictor of
response (at p<0.05). These are summarised in Table 2; this should be cross-
referenced with Figure 1 which shows between-group comparison.
 
***INSERT TABLE 2 ABOUT HERE***
 
Wald test results indicate for which questions an overall significant difference in
response exists across categories of sexual orientation – statistical significance for
these tests is included in parentheses in the summary of results which follows. For
these questions we explored post-estimation probabilities of differences between
each sexual orientation category (see Figure 1). Below, we report on questions in
which post-estimation results for sexual orientation categories were significant
(p<0.05; for full results, see supplementary material.)
 
 
***INSERT FIGURE 1 ABOUT HERE***
 
Questions about cancer diagnosis
Bisexual respondents were significantly less likely to report that they had had a
diagnostic test for cancer within the previous 12 months (p=.03). They were also
more likely to respond that they were told by a nurse or other healthcare professional
(than a doctor) that they had cancer, and significantly less likely to have received this
information through lay-referral (via friend or relative) than other sexual orientation
participant categories (p=.03). When asked whether they had been given any written
information at diagnosis, bisexual respondents were more likely to respond “Yes, but
it was difficult to understand” (p=.01).
Questions about treatment decisions
Bisexual respondents were more likely to report that they would have liked a choice
of treatment option but were not offered one, and lesbian/gay respondents more
frequently responded that that were not given a choice because there was only one
suitable treatment type available (p<.01). Bisexual respondents reported that they
were not as involved as much as they would have liked to have been in decisions
about their care and treatment (p<.01), and that they were not given written
information about side-effects of treatments; lesbian/gay respondents more
frequently responded that they received this information, but that it was difficult to
understand (p=.01).
Questions about relationships with healthcare professionals
When asked about their relationships with healthcare professionals, bisexual
respondents were more likely to indicate that it was difficult to contact their nurse
specialist (p<.01), and that they got understandable answers to important questions
only “some of the time” (p=.01). A higher proportion of bisexual respondents
indicated that ward nurses talked in front of them as if they were not there (p=.02). In
response to the question “If your family or someone else close to you wanted to talk
to a doctor, did they have enough opportunity to do so?”, a higher proportion of both
lesbian/gay and bisexual respondents indicated that either no family or friends were
involved, or that they did not want their family or friends involved, compared with
heterosexual respondents (p<.01). That is, the difference was not one of a lack of
opportunity provided to talk to doctors but rather that there wasn’t a significant
person involved to take up such opportunity.
Questions about care after treatment had finished
During aftercare, bisexual respondents were less likely to report they had been given
enough care and help from health and social services (p=.03), and reported that
hospital staff did everything possible to control radiotherapy side effects, “only to
some extent” (p=.05). Lesbian/gay respondents were less likely than both
heterosexuals and bisexuals to have received a written care or assessment plan
(p=.02). Once again, when asked whether family or those close to them were given
all the information they required regarding home care, LGB respondents were more
likely to have replied that either no family or friends were involved, or that they did
not want their family or friends involved (p<.01).
Questions about psychosocial support and overall care
Lesbian/gay respondents were more likely to indicate that they were not treated with
dignity and respect through their cancer care (p=.01). When asked whether they felt
that they were treated as “a set of symptoms” rather than a whole person, bisexual
respondents were more likely to respond “yes, often” (p=.01).
 
 
 
 
Discussion
This study offers an important contribution to understanding the cancer experiences
of a marginalised socio-demographic group. In undertaking a large-scale secondary
analysis of a substantial nationally-administered survey of cancer patient
experiences, we build on the findings reported by Kamen et al (2015); secondary
analysis of this type ensures that our findings are not limited by design
considerations or specific sociodemographic or clinical inclusion criteria.
Contextualising the findings
Provision and utilization of healthcare services amongst LGB people are affected by
the specific legislative and socio-cultural framework in each country (Quinn et al,
2015). Given recent changes in the landscape for sexual equality in the UK (for
example the inclusion of sexual orientation in equality and discrimination legislature
(Equality Act, 2010) and the introduction of the Civil Partnership Act (2004) and so
forth), it is both timely, and useful to explore potential inequality in cancer
experiences in a UK sample. Despite the UK focus of our data, many findings have
global implications, and are relevant especially in the context of the International
Psycho-Oncology Society (IPOS) Lisbon Declaration (IPOS, 2014) which advocates
quality psychosocial oncology care as a fundamental human right for all; empirical
research that identifies and addresses inequality is essential achieving this goal.
Consistent with broader literature (Boehmer et al, 2011; Kamen et al, 2015; Boehmer
et al, 2012; Kamen et al, 2014), our findings suggest a pattern of inequalities in
cancer care for LGB people, though where earlier studies focus on patient-reported
outcome measures (e.g distress), ours focus on healthcare experiences; the findings
are thus complementary and broaden our understanding of diversity in cancer care.
This was especially true for bisexual respondents, a finding not so explicitly evident
in previous research. For lesbian/gay respondents, specific aspects of care were
often equivalent to heterosexual respondents. However, the experiences of lesbian
and gay respondents mirror bisexual respondents on key themes related to patient-
centred care provision and social isolation, each of which remain of concern.
The patterning of responses to the sexual orientation question on the NCPES
highlight difficulties with the disclosure of sexual orientation This is likely to be
reflected in face to face disclosure within healthcare consultations. Disclosing sexual
orientation to healthcare providers is stressful (Kamen et al, 2015) and can result
from perceptions of heteronormativity and heterosexism (Irwin, 2007; Meyer, 2003),
stigmatization (Whitehead, Shaver & Stephenson, 2015), discrimination (Elliott et al,
2015; Quinn et al, 2015), fears of substandard treatment (Boehmer & Case, 2004),
poor treatment of same-sex partners (Barbara, Quandt & Anderson, 2001), and
heterosexist assumptions of sexual orientation (Hinchliff, Gott & Galena, 2005;
Neville & Henrickson, 2006). This can affect numerous aspects of engagement and
satisfaction with healthcare including utilization of services (Whitehead, Shaver &
Stephenson, 2015), and poor communication (Morrison & Dinkel, 2012).
Responses to the NCPES indicated a substantially greater number of significant
differences in perception of cancer care experiences for bisexual respondents;
greater even than for those identifying as lesbian or gay. Discrimination toward
bisexual people (and indeed transsexual/ transgender communities) compared with
lesbian and gay people in the UK has been slower to improve; marginalization
comes from multiple sources, including from within the lesbian/gay community
(Clarke et al, 2010). We postulate that a greater number of negative cancer care
experiences reported by this group may be a consequence of this continued
inequality, and lack of acceptance and understanding by wider society. Health issues
such as cancer, may produce additional burden onto this already vulnerable group,
and this needs to be better understood to enable intervention and service provision
to adequately address these differences.
Of course, there remains the possibility that the differences in experiences identified
in this study are caused by unmeasured, tertiary variables. It is in some cases
difficult to reconcile, for example, the extent of differences observed for a non-
disclosing bisexual cancer patients who may attend clinic with an opposite-sex
partner. Even though in this case there may be no explicit prompt to disclose sexual
orientation to a healthcare provider, there is indeed an implicit need to do so in order
to ensure optimal patient-centred communication and care. The unwillingness to
disclose on the part of the patient (as discussed above), combined with a lack of
sexual orientation monitoring and questioning on the part of the healthcare provider,
may well act as a substantial barrier to disclosure. Future research is clearly required
to more fully explain differences in cancer experiences between those identifying as
lesbian, gay and bisexual.
Our specific findings orient around three central themes:
1. Patient-centred care and shared decision making
Bisexual respondents were significantly more likely to have reported that they were
informed about their diagnosis by a nurse or other healthcare professional, but
thereafter to have found it difficult to contact nurse specialists and to get
understandable answers from them. They similarly reported that they were
dissatisfied with their interaction with nurses on hospital wards, and the care and
help provided by both health and social care services after leaving hospital. With a
focus on patient-centred holistic care, the nursing workforce remains one of the most
important sources of support and care for cancer patients (Hulbert-Williams, 2016);
previous research has demonstrated that nurse-led psychosocial care reduces
distress (Lewis et al, 2009), and provides an effective model of follow-care (Swanson
& Koch, 2010). That this wasn’t the case for bisexual respondents in this survey is
surprising and necessitates further empirical attention; this should be prioritised in
future research.
Despite wanting to be more involved in treatment decision-making, bisexual
respondents indicated that they were not given a choice of treatments; similarly,
lesbian/gay respondents indicated that they were informed that a choice of treatment
was not available to them. This is an important finding given the global recognition of
the importance of patient (and friends/family’s) involvement in healthcare decision-
making. Irwin suggests that this discrepancy exists for LGB people as a direct result
of homophobia and heterosexism (Irwin, 2007) but does not offer a causal
explanation. Our findings confirm the continuation of these inequalities in the UK
cancer care context.
2. Implicit inequality via heteronormativity in information provision
LGB respondents significantly differed from heterosexual respondents in their
satisfaction with written information provided at diagnosis, treatment and aftercare.
Broader literature suggests that perceived discrimination can arise where outward
behaviour does not differ, but instead by omission. Typical communication strategies
and information resources, whilst not explicitly homophobic, can perpetuate
heteronormativity. Conversational micro-cues (Kitzinger, 2005a; Kitzinger, 2005b)
and an over-reliance on heterosexual imagery (Blank, 2005), can create an implicit
exclusionary context, leading to low levels of satisfaction. Sexual orientation equality
is not necessarily about treating all people the same, but matching care to individual
needs for all patients regardless of sexual orientation (Quinn et al, 2015), and this
doesn’t seem to have been the case with respect to these specific cancer care
experiences.
3.  Social Isolation
This tacit exclusionary context becomes more problematic when considering that
LGB respondents either do not have, or are choosing to exclude, significant others
from their cancer experience. It is unfortunate that the survey didn’t include a
question on relationship status as this may have helped to further understand
responses to these questions and to better contextualise the findings against Kamen
et al’s US data (Kamen et al, 2015). This finding is not unique to cancer care—for
 LGB patients with dementia, the main source of informal care is not usually provided
by family, with reliance instead on friends (Peel & McDaid, 2015)—and has been
explained elsewhere as a deliberate strategy to protect family and friends from
negative consequences of homophobia and heteronormativity (Barbara, Quandt &
Anderson, 2001); the same may well be true in the cancer context. All patients
should be entitled to choose the degree of involvement of their loved ones (friends or
family) in their care, but if that process involves sexual orientation disclosure, it is
possible that choosing to exclude them may be regarded as a safer option. This
paints a worrying picture of continued social isolation through cancer as previously
reported (Grossman, D’Augelli & Hershberger, 2000).  
Study evaluation
Study evaluation
There are limitations to our analyses, many of which are common to secondary
analysis methodology. First, findings are based on only a small and disproportionate
sub-sample of those identifying as LGB. Whilst gender has been identified as an
important covariate in understanding sexual orientation cancer care experience
(Kamen et al, 2015), we chose to maintain lesbian and gay respondents as a single
category (statistically controlling for gender effects); this method not only matched
the response options from the original survey but also increased statistical power for
comparison analysis.  However in doing so we admittedly lose the distinct
experiences of these discrete groups.
Not including bisexual and ‘other’ respondents into this same category reflects a
pragmatic attempt to minimise further dilution of findings. Whilst there were sufficient
numbers to gain meaningful insight into the experiences of bisexual repondents, the
group size for the ‘other’ category was too small for analysis. Choosing ‘other’ is,
however, a meaningful response choice (rather than “prefer not to say”): it suggests
a sexual orientation that cannot neatly be defined by heterosexual, gay, lesbian or
bisexual (for example asexual, pansexual, sexually fluid and so forth). A recent
publication reports that levels of common mental disorder symptoms (e.g.
depression, anxiety) in individuals identifying as ‘other’ are more similar to those
identifying as LGB than they are to heterosexuals (Semlyen et al, 2016). It is
reasonable to ask, therefore, whether this shared non-heterosexual identity will
impact on other aspects of life, and whether their cancer care experiences too may
be poorer than those of heterosexual respondents. There is clearly more work to be
done on understanding the cancer care experiences in those identifying as non-
heterosexual or LGB, thus highlighting a further important question for future
research.
Similarly, missing sexual orientation data was problematic: other studies have
suggested that LGB people more often refuse to disclose sexual orientation (Ellison
& Gunstone, 2009) and so the high proportion of missing data here is likely
representative of the experiences of a broader group of non-disclosing LGB cancer
patients. The combined effects of missing data on sexual orientation and statistical
control variables resulted in 16% respondent exclusion which is an unavoidable
limitation. If we were to make recommendations for future iterations of the NCPES,
we would suggest that response options to the question on sexual orientation be re-
considered to ensure that the data gathered is both more meaningful and usable in
data analysis.
A particular strength of our study is that we did not limit our analysis to a particular
sociodemographic or clinical subgroup. We undertook a statistically robust approach
to identifying sociodemographic and clinical confounding variables (ruling out some
expected confounders, such as ethnicity (Naylor, Ward & Polite, 2012)) and we
corrected for these as appropriate in comparative analysis. This is especially
important in the case of age; older LGB individuals are likely to have a longer history
of experiencing homophobia than younger generations. This is likely to affect
interaction with healthcare professionals which in turn may have affected care
experiences.
Specific wording of some questions is problematic but something we had little control
over; whilst it is important to consider the findings with appropriate caution we do not
think this undermines the key findings from our work– our aim was exploratory and in
that context we identify important areas of future study.  We nonetheless urge those
who may replicate this survey to consider nuanced language: some questions have
ambiguous and vague wording; others, for example the question about time to first
appointment, are not compliant with good practice guidelines (in this case, the
Aarhus Statement (Weller et al, 2012)).  There are known differences between self-
reported sexual orientation and sexual practice (Mercer et al, 2013) and so asking
about sexual attraction and behaviour would be useful (Joloza et al, 2010) as would
directly asking whether respondents feel that their sexual orientation impacted on
cancer experiences.
 
 
Finally, it is important to note that this work undertakes a secondary analysis of
health service evaluation questionnaire rather than any validated psychometric tools.
As such it has not been exposed to rigorous validity testing. We would caution
readers to bear this in mind when considering the implications of the findings.
 
Implications of the findings
Retrospective self-report data has multiple methodological pitfalls. Not least, survey
questions ask about what individuals remember and report, not what actually
happened. It may be that there was no real difference in the care and support
provided to LGB patients, but that they remember or evaluate it somehow differently,
for known or unknown reasons.  Even if the differences are perceptual rather than
behavioural, however, this may indicate a lack of bi-directional understanding
between patient and healthcare professionals, and that has important clinical
implications. In the context of the varied range of differences found in this analysis, it
is understandable why lesbian/gay and bisexual respondents differed in their
perceptions of how much they were treated with “dignity and respect”, and “as a set
of symptoms rather than a whole person”.  
These differences may relate to communication (both direct and implicit; written and
verbal) between patients and healthcare teams. More explicit opportunity is needed
to facilitate disclosure of sexual orientation to lower consequent burden during times
of crisis, such as cancer diagnosis (Boehmer & Case, 2004). This perceived burden
can be reduced with approaches that reduce perceptions of heteronormativity and
implicit discrimination. Previous research advocates a need for more training to
support healthcare professionals in providing cancer care to sexual minority groups
(Kamen et al, 2015; Reygan & D’Alton, 2013), and our findings add further weight to
this. Such training may be beneficial in creating an environment in which comfortable
communication exists (Klitzman & Greenberg, 2002) and where psychosocial
support needs can be understood and met (Hinchliff, Gott & Galena, 2005)
Furthering opportunities to acknowledge and discuss non-normative family dynamics
and more inclusionary practice toward the acceptability of non-traditional modes of
caring and support should be recognised, and may provide appropriate outcomes for
staff training and development (Harding, Epiphaniou & Chidgley-Clark, 2012).
 
Efforts to standardise monitoring of sexual orientation within healthcare and research
are important to enable on-going analysis of, and opportunities to address, health
inequalities (Kamen et al, 2015). On the basis of this study, and where it sits within a
broader context of LGB research in cancer, a number of question still remain. A
programme of mixed methods, interdisciplinary research is needed to empirically
examine the varied issues raised within this paper.
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Table 1:  Summary sociodemographic and clinical
description for heterosexual, lesbian/gay and bisexual sub-
samples
  Heterosexual
(N = 61,398)
Lesbian/Gay
(N = 425)
Bisexual
(N = 143)
Age Mean (SD) 66 (12.3) 57.5 (13.4) 64 (14.9)
Gender N (%)    
 Female 32,485 (52.9) 173 (40.7) 62 (43.4)
 Male 28,913 (47.1) 252 (59.3) 81 (56.6)
Ethnicity N (%)    
 British / Irish 57,342 (99.1) 379 (0.7) 121 (0.2)
 Other White 1,118 (97.9) 20 (1.8) 4 (0.35)
 Other 2,174 (98.7) 18 (0.8) 11 (0.5)
Time since diagnosis N (%)    
 < 1 year 40,051 (66.2) 286 (67.8) 83 (61)
 1-5 years 15,128 (25.0) 112 (26.5) 37 (27)
 > 5 years 5,138 (8.5) 24 (5.7) 15 (11.0)
 Don’t know/ can’t remember 165 (0.3) 0 (0.0) 2 (1.5)
Employment N (%)    
 Full time 10,299 (17.0) 142 (33.7) 30 (21.3)
 Part time 5,566 (9.2) 38 (9.0) 17 (12.1)
 Homemaker 1,698 (2.8) 4 (1.0) 3 (2.1)
 Student 162 (0.3) 6 (1.4) 1 (0.7)
 Retired 37,740 (62.4) 148 (35.1) 72 (51.1)
 Unemployed (seeking) 414 (0.7) 9 (2.1) 1 (0.7)
 Unemployed (health) 3,392 (5.6) 60 (14.2) 12 (8.5)
 Other 1,263 (2.1) 15 (3.6) 5 (3.6)
Comorbidities N    
 Deafness 6,267 (10.9) 32 (8.0) 19 (14.0)
 Blindness 1,378 (2.39) 3 (0.8) 3 (2.2)
 Physical disability 8,329 (14.5) 53 (13.2) 21 (15.4)
 Learning disability 222 (0.39) 2 (0.5) 2 (1.5)
 Mental health 1,188 (2.06) 33 (8.2) 8 (5.9)
 Long standing illness 8,108 (14.1) 74 (18.5) 22 (16.2)
 None 37,455 (65.1) 244 (61.0) 76 (55.9)
Comorbidities Mean (SD) 0.4427 (0.6681) 0.4913 (0.6786) 0.5515 (0.6973)
Ethnicity N (%)    
 British 56,524 (93.2) 370 (88.7) 117 (86.0)
 Irish 818 (1.4) 9 (2.2) 4 (2.9)
 Other White 1,118 (1.8) 20 (4.8) 4 (2.9)
 White & Black Caribbean 77 (0.1) 2 (0.5) 1 (0.7)
 White & Black African 29 (0.1) 2 (0.5) 0 (0.0)
 White & Asian 86 (0.1) 0 (0.0) 0 (0.0)
 Other mixed 70 (0.1) 4 (0.1) 1 (0.7)
 Asian 477 (0.8) 2 (0.5) 4 (2.9)
 Pakistani 179 (0.3) 1 (0.2) 1 (0.7)
 Bangladeshi 49 (0.1) 0 (0.0) 0 (0.0)
 Other Asian 205 (0.3) 1 (0.2) 1 (0.7)
 Caribbean 438 (0.7) 3 (0.7) 1 (0.7)
 African 286 (0.5) 1 (0.2) 2 (1.5)
 Other black 35 (0.1) 0 (0.0) 0 (0.0)
 Chinese 151 (0.3) 1 (0.2) 0 (0.0)
 Other 92 (0.2) 1 (0.2) 0 (0.0)
Tumour Group    
 Brain/Central Nervous System 663 2 7
 Breast 12,601 23 71
 Colorectal / Lower
 Gastrointestinal 7,894 14 61
 Gynaecological 3,436 8 26
 Haematological 10,341 35 73
 Head and Neck 2,177 7 18
 Lung 4,431 4 29
 Other 2,465 3 17
 Prostate 5,045 18 38
 Sarcoma 629 0 14
 Skin 1,662 4 11
 Upper Gastrointestinal 3,834 8 28
 Urological 6,220 17 32
 
Table 2. Logistical regression model summaries showing the significance of sexual
orientation as a predictor of difference responses (note: includes only those
significant at p<.05; full results are provided as supplementary material and question
numbers included for cross reference; see table footnote for key to model type).
Question Responses
included in
model (n)
Wald test
results of
sexual
orientation as
a predictor
  2 P
  2 P
Questions about cancer diagnosis
 In the last 12 months have you had diagnostic test(s)
for cancer at one of the hospitals named in the
covering letter?
562951 7.19 0.03
 Who first told you that you had cancer? 570173 20.15 0.03
 When you were told you had cancer, were you given
written information about the type of cancer you had?
574653 17.48 0.01
Questions about treatment decisions
 Before your cancer treatment started, were you given
a choice of different types of treatment?
554653 27.24 <0.01
 Before you started your treatment, were you given
written information about the side effects of
treatment(s)?
531763 13.93 0.01
 Were you involved as much as you wanted in decision
about your care and treatment?
554042 11.50 <0.01
Questions about relationships with healthcare professionals
 How easy is it for you to contact your nurse specialist? 482263 19.68 <0.01
 When you have important questions to ask your
clinical nurse specialist, how often do you get answers
you can understand?
470503 18.17 0.01
 Did ward nurses talk in front of you as if you weren’t
there?
386962 8.31 0.02
 If your family or someone else close to you wanted to
talk to a doctor, did they have enough opportunity to
do so?
389363 63.59 <0.01
Questions about care after treatment had finished
 After leaving hospital, were you given enough care
and help from health and social services?
382343 13.96 0.03
 Did hospital staff do everything possible to control the
side effects of radiotherapy?
538393 15.68 0.05
 Have you been offered a written assessment and care
plan?
482141 8.20 0.02
 Did the doctors or nurses give your family or someone
close to you all the information they needed to help
care for you at home?
382673 61.93 <0.01
Questions about psychosocial support and overall care
 Were you treated with dignity and respect by the
doctors and nurses and other hospital staff?
386522 8.53 0.01
 Sometimes people with cancer feel they are treated as
“a set of symptoms” rather than a whole person. In
your NHS care over the last year did you feel like that?
 
 
567782
9.55 0.01
1logistic regression; 2ordered logistic regression; 3multinomial
logistic regression​
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Figure 1. Between group comparisons in response likelihood for those questions
reaching p<.01 significance in Wald tests.
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Supplementary table:  Results of statistical analysis of difference in response by
sexual identity category for all questions in the patient experience survey.
 
Question Responses
included in
model (n)
Model post
estimation:
Wald test
results of
sexuality (L/G,
B, H) as a
predictor
  2 P
1: Before you were told you needed to go to the hospital
about cancer, how many times did you see your GP
(family doctor) about the health problem cause by
cancer?
56044 7.71 0.46
2: How do you feel about the length of time you had to
wait before your first appointment with a hospital doctor?
56656 1.81 0.40
3: How long was it from the time you first thought
something might be wrong with you until you first saw a
hospital doctor?
54978
​
3.05 0.22
4: Did your health get worse, get better or stay about the
same while you were waiting for your first appointment
with a hospital doctor?
56551 1.73 0.42
5: In the last 12 months, have you had diagnostic test(s)
for cancer such as an endoscopy, biopsy, mammogram,
or scan at one of the hospitals named in the covering
letter?
56295 7.19 0.03
6: Beforehand, did a member of staff explain the purpose
of the test?
50395 11.31 0.08
7: Beforehand, did a member of staff explain what would
be done during the test procedure(s)?
50629 4.33 0.63
8: Beforehand, were you given written information about
your test(s)?
47560 2.82 0.83
9: Were the results of the test(s) explained in a way you
could understand?
50598 5.07 0.53
​
​
​
​
​
​
10: Who first told you that you had cancer? 57017 20.15 0.03
11: When you were first told that you had cancer, had
you been told you could bring a family member or friend
with you?
54357 8.32 0.22
12: How do you feel about the way you were told you
had a cancer?
57397 3.43 0.18
13: Did you understand the explanation of what was
wrong with you?
57420 2.09 0.72
14: When you were told you had cancer, were you given
written information about the type of cancer you had?
54765 17.48 0.01
15: Before your cancer treatment started, were you given
a choice of different types of treatment?
55465 27.24 <0.01
16: Do you think your views were taken into account
when the team of doctors and nurses caring for you were
discussing which treatment you should have?
53934 4.67 0.59
17: Were the possible side effects of treatment(s)
explained in a way you could understand?
56255 9.36 0.15
18: Before you started your treatment, were you given
written information about the side effects of treatment(s)?
53176 13.93 0.01
19: Before you started your treatment, were you also told
about any side effects of the treatment that could affect
you in the future rather than straight away?
53316 4.98 0.55
20: Were you involved as much as you wanted to be in
decisions about your care and treatment?
55404 11.50 <0.01
21: Were you given the name of a clinical nurse
specialist who would be in charge of your care?
54857 3.04 0.22
22: How easy is it for you to contact your clinical nurse
specialist?
48226 19.68 <0.01
23: The last time you spoke to your clinical nurse
specialist, did she/he listen carefully to you?
46682 3.45 0.18
24: When you have important questions to ask your
clinical nurse specialist, how often do you get answers
you can understand?
47050 18.17 0.01
25: Did hospital staff give you information about support
or self-help groups for people with cancer?
54092 9.15 0.06
26: Did hospital staff discuss with you or give you
information about the impact cancer could have on your
work life or education?
54447 5.62 0.23
27: Did hospital staff give you information about how to
get financial help or any benefits you might be entitled
to?
54929 1.39 0.85
28: Did hospital staff tell you that you could get free
prescriptions?
55643 6.96 0.14
29: Have you seen information (such as leaflets, posters,
information screens etc.) about cancer research in your
hospital?
56825 0.85 0.65
30: Since your diagnosis, has anyone discussed with you
whether you would like to take part in cancer research?
54107 0.40 0.82
31: If yes, did you then go on to take part in cancer
research?
172841 3.21 0.20
32: During the last 12 months, have you had an
operation (such as removal of a tumour or lump) at one
of the hospitals named in the covering letter?
57054 2.72 0.26
33: Before you had your operation, did a member of staff
explain what would be done during the operation?
323732 2.11 0.91
34: Beforehand, were you given written information about
your operation?
3298662 8.04 0.10
35: After the operation, did a member of staff explain
how it had gone in a way you could understand?
325262 6.17 0.40
36: During the last 12 months, have you had an
operation or stayed overnight for cancer care at one of
the hospitals named in the covering letter?
57001 0.84 0.66
37: When you had important questions to ask a doctor,
how often did you get answers that you could
understand?
39030 9.37 0.15
38: Did you have confidence and trust in the doctors
treating you?
39108 1.86 0.39
39: Did doctors talk in front of you as if you weren’t
there?
39037 4.83 0.09
40: If your family or someone else close to you wanted to
talk to a doctor, did they have enough opportunity to do
so?
38936 63.59 <0.01
41: When you had important questions to ask a ward
nurse, how often did you get answers you could
understand?
38944 8.88 0.18
42: Did you have confidence and trust in the ward nurses
treating you?
38989 0.20 0.91
43: Did ward nurses talk in front of you as if you weren’t
there?
38696 8.31 0.02
44: In your opinion, were there enough nurses on duty to
care for you in hospital?
38720 2.33 0.31
45: While you were in hospital did you ever think that the
doctors or nurses were deliberately not telling you certain
things that you wanted to know?
38953 4.14 0.13
46: While you were in hospital, did it ever happen that
one doctor or nurse said one thing about your condition
or treatment, and another said something different?
38881 2.75 0.25
47: While you were in hospital did the doctors and nurses
ask you what name you prefer to be called by?
38741 2.43 0.30
48: Were you given enough privacy when discussing you
condition or treatment?
39045 2.84 0.24
49: Were you given enough privacy when being
examined or treated?
39128 3.38 0.18
50: Were you able to discuss any worries or fears with
staff during your hospital visit?
39028 12.37 0.14
51: Do you think the hospital staff did everything they
could to help control your pain?
38553 9.19 0.16
52: Were you treated with respect and dignity by the
doctors and nurses and other hospital staff?
38652 8.53 0.01
53: Were you given clear written information about what
you should or should not do after leaving hospital?
38492 3.66 0.45
54: Did hospital staff tell you who to contact if you were
worried about your condition or treatment after you left
hospital?
37464 0.09 0.96
55: Did the doctors or nurses give your family or
someone close to you all the information they needed to
help care for you at home?
38267 61.93 <0.01
56: After leaving hospital, were you given enough care
and help from health or social services (for example,
district nurses, home helps, or physiotherapists)?
38234 13.96 0.03
57: Did hospital staff do everything possible to control the
side effects of radiotherapy?
53839 15.68 0.05
58: Did hospital staff do everything possible to control the
side effects of chemotherapy?
54769 5.08 0.75
59: While you were being treated as an outpatient or day
case, did hospital staff do everything they could to help
control your pain?
54709 8.56 0.20
60: Whilst you were being treated as an outpatient or day
case, were you given enough emotional support from
hospital staff?
54759 1.59 0.95
61: In the last 12 months, have you had an outpatients
appointment with a cancer doctor at one of the hospitals
named in the covering letter?
56297 0.90 0.64
62: The last time you had an appointment with a cancer
doctor, did they have the right documents, such as
medical notes, x-rays and test results?
51896 0.32 0.85
63: As far as you know, was your GP given enough
information about yoru condition and the treatment you
had at the hospital?
46786 0.36 0.84
64: Do you think the GPs and nurses at your general
practice did everything they could to support you while
you were having cancer treatment?
56348 2.96 0.81
65: Did the different people treating and caring for you
(such as GP, hospital doctors, hospital nurses, specialist
nurses, community nurses) work well together to give
you the best possible care?
54508 3.78 0.88
66: Have you had treatment from any of the following for
your cancer? (tick all that apply)
Not included in analysis of
this dataset – see main
text for explanation
67: How much information were you given about your
condition and treatment?
55973 3.09 0.21
68: Have you been offered a written assessment and
care plan? A care plan is a document that sets out your
needs and goals for caring for your cancer. It is an
agreement or plan between you and your health
professional to help meet those goals.
48214 8.20 0.02
69: Sometimes people with cancer feel they are treated
as “a set of cancer symptoms”, rather than a whole
person.  In your NHS care over the last year did you feel
like that?
56778 9.55 0.01
70: Overall, how would you rate your care. 57124 3.59 0.17
 
1 Lower response to this question because completion was only
necessary where participants answered ‘yes’ to Q30.
2 Lower response rates as participants were only invited to
complete these questions if they had answered ‘yes’ to Q32.
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